| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 09/02/2018 | 15h13 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 20h22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 18h20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 18h20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 18h20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |